Biopsy-derived organoids, accurate models of disease, are used to search for new drugs. Now, results obtained by a study led by the University of Trento in collaboration with Bambino Gesù Children’s Hospital in Rome may pave a path to an organoid that could be used to study two common, aggressive childhood brain cancers. The model organ for this research project is the best pediatric brain tumor model developed so far and can be used to test new drugs. The results of the project are published in the Nature Protocols.
This article was originally published on MedicalXpress.com
